Our Partners

The Department of Veterans Affairs (VA), Office of General Counsel (OGC), the Veterans Health Administration (VHA) and the National Association of Veterans Research and Education Foundations (NAVREF) have partnered to develop a series of model agreements for research collaborations benefiting our nation’s veterans. These agreements are referred to as Cooperative Research and Development Agreements (CRADAs) and allow entities such as pharmaceutical and medical device industry to conduct collaborative research within the VA system. VACREF has collaborative research and development agreements with many of the major pharmaceutical industries including, but not limited to the following:

    – AbbVie
    – Anthos Therapeutics
    – Astra Zeneca
    – Bayer Healthcare
    – Baxter Healthcare
    – Beth Israel Deaconess Medical Center
    – Bessor Pharma
    – Boehringer-Ingelheim
    – Brain Plasticity Inc.
    – Bristol Myers Squibb
    – Conatus
    – Exalenz
    – Exosome Diagnostics
    – Glaxo Smith Kline
    – Merck
    – Myriad Genetic Laboratories
    – Novartis
    – Nucleix
    – Pfizer
    – Resmed
    – Respironics
    – Samueli Foundation
    – Sanofi-Aventis
    – St. Francis Hospital
    – TheraNova

 

VA Connecticut Health Care System (VACHCS) researchers may also seek funding from private foundations or through Federal funding sources such as the VA Office of Research and Development and the National Institutes of Health.